Literature DB >> 18336322

Lantibiotic immunity.

Lorraine A Draper1, R Paul Ross, Colin Hill, Paul D Cotter.   

Abstract

Lantibiotics are a diverse family of bacterially synthesized antimicrobial peptides produced by gram-positive bacteria. They usually have a broad spectrum of targets, often including closely related strains. The production of lantibiotics must thus be coupled with a mechanism by which the producing strain can protect itself from the lethal action of its own antimicrobial compound. This mechanism is referred to as immunity. Lantibiotic immunity is usually provided by one, or both, of two methods i.e. by a specific immunity peptide (designated LanI) and/or a specialised ABC transporter system (designated LanFE(G)). Significantly, although the specific immunity peptides function in a similar manner, there is very little homology between them. This is reflected in the specific nature of the immunity provided. Finally, of equal importance is the manner in which these immunity determinants are regulated such that their expression is timed to occur with, or immediately prior to, lantibiotic production to ensure successful self-protection.

Mesh:

Substances:

Year:  2008        PMID: 18336322     DOI: 10.2174/138920308783565750

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  44 in total

1.  The spiFEG locus in Streptococcus infantarius subsp. infantarius BAA-102 confers protection against nisin U.

Authors:  Lorraine A Draper; John R Tagg; Colin Hill; Paul D Cotter; R Paul Ross
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

2.  The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.

Authors:  Barry Collins; Nicola Curtis; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Antimicrob Agents Chemother       Date:  2010-07-19       Impact factor: 5.191

3.  Staphylococcus colonization of the skin and antimicrobial peptides.

Authors:  Michael Otto
Journal:  Expert Rev Dermatol       Date:  2010-04

4.  Novel Probiotic Mechanisms of the Oral Bacterium Streptococcus sp. A12 as Explored with Functional Genomics.

Authors:  K Lee; A R Walker; B Chakraborty; J R Kaspar; M M Nascimento; R A Burne
Journal:  Appl Environ Microbiol       Date:  2019-10-16       Impact factor: 4.792

5.  SmbFT, a putative ABC transporter complex, confers protection against the lantibiotic Smb in Streptococci.

Authors:  Saswati Biswas; Indranil Biswas
Journal:  J Bacteriol       Date:  2013-10-11       Impact factor: 3.490

6.  Nisin H Is a New Nisin Variant Produced by the Gut-Derived Strain Streptococcus hyointestinalis DPC6484.

Authors:  Paula M O'Connor; Eileen F O'Shea; Caitriona M Guinane; Orla O'Sullivan; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2015-04-03       Impact factor: 4.792

Review 7.  Lantibiotic resistance.

Authors:  Lorraine A Draper; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Microbiol Mol Biol Rev       Date:  2015-06       Impact factor: 11.056

8.  Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.

Authors:  Shradha Basi-Chipalu; Jasmin Dischinger; Michaele Josten; Christiane Szekat; Annegret Zweynert; Hans-Georg Sahl; Gabriele Bierbaum
Journal:  Appl Environ Microbiol       Date:  2015-03-13       Impact factor: 4.792

9.  The First structure of a lantibiotic immunity protein, SpaI from Bacillus subtilis, reveals a novel fold.

Authors:  Nina A Christ; Sophie Bochmann; Daniel Gottstein; Elke Duchardt-Ferner; Ute A Hellmich; Stefanie Düsterhus; Peter Kötter; Peter Güntert; Karl-Dieter Entian; Jens Wöhnert
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

Review 10.  Bacteriocin as weapons in the marine animal-associated bacteria warfare: inventory and potential applications as an aquaculture probiotic.

Authors:  Florie Desriac; Diane Defer; Nathalie Bourgougnon; Benjamin Brillet; Patrick Le Chevalier; Yannick Fleury
Journal:  Mar Drugs       Date:  2010-04-04       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.